Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) disclosed a Next Day Disclosure Return detailing its latest on-market share repurchase.

Key points • Transaction date: 08 May 2026 • Shares repurchased: 148,400 H-shares • Price range: HKD 3.48–3.52 per share; volume-weighted average price HKD 3.507 • Aggregate consideration: HKD 0.52 million • Repurchase method: on the Hong Kong Stock Exchange

Capital structure after the transaction • Issued shares outstanding (excluding treasury): reduced to 4,467.78 million, down 0.0033% from the previous day. • Treasury shares: increased to 54.55 million. • Total issued shares (including treasury): unchanged at 4,522.33 million.

Repurchase mandate utilisation • Authorised under shareholder mandate dated 27 May 2025 to buy back up to 451.56 million shares. • Cumulative repurchases under the mandate: 47.90 million shares, equivalent to 10.61% of the issued share base on the mandate date. • Moratorium: the company is restricted from issuing new shares or disposing of treasury shares until 08 June 2026.

The board confirmed that the repurchase complied with Hong Kong Listing Rules and all relevant legal requirements.